We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GSK Strengthens Vaccines Business with Acquisition of Okairos

News   May 31, 2013

 
GSK Strengthens Vaccines Business with Acquisition of Okairos
 
 
 

RELATED ARTICLES

Increasing the Odds of Synthetic Chemistry Success

News

Chemists show how analyzing previously published chemical reaction data can predict how hypothetical reactions may proceed, narrowing the range of conditions chemists need to explore. Their algorithmic prediction process, which includes aspects of machine learning, can save valuable time and resources in chemical research.

READ MORE

Vaccine Strategy Boosts T-Cell Therapy

News

In a study of mice, the researchers found that they could completely eliminate solid tumors in 60 percent of the animals that were given T-cell therapy along with the booster vaccination. Engineered T cells on their own had almost no effect.

READ MORE

Enhancing the Infection-fighting Potential of Natural Products

News

A team has identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE